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CHAPTER I 
 
INTRODUCTION 
 
Objective 
 The objective of this work was to characterize how variations in gold nanoparticle 
diameter affect the packing density, or functionalization efficiency, of surface 
functionalized thiolated poly(ethylene glycol) using a “label-free” conjugate 
quantification technique.  Five gold particle diameters were selected and conjugated with 
poly(ethylene glycol) using a citrate-thiol place exchange reaction forming PEGylated 
gold monolayer protected clusters.  The gold clusters were characterized using 
ultraviolet/visible spectroscopy and dynamic light scattering to evaluate gold solution 
concentration and conjugation confirmation, respectively.  Gold clusters were 
decomposed using iodine and the conjugates were enumerated using nuclear magnetic 
resonance (NMR) spectroscopy and inductively coupled plasma mass spectroscopy (ICP-
AES). 
 
Specific Aims 
1) Obtain colloidal gold particles of varying size and gain the ability to determine 
unknown concentrations. 
2) Functionalize colloidal gold particles with thiolated poly(ethylene glycol) at 
constant reaction concentration. 
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3) Confirm conjugation of thiolated poly(ethylene glycol) to colloidal gold particles 
using a quantitative method. 
4) Enumerate the number of conjugated ligands on the gold surface for each particle 
size using NMR spectroscopy and compare to predicted results. 
5) Enumerate the number of conjugated ligands on the gold surface for each particle 
size using ICP-AES and compare to NMR and predicted results. 
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CHAPTER II 
 
SIZE DEPENDENT FUNCTIONALIZATION EFFICIENCY OF POLYETHYLENE-
GLYCOL CONJUGATED GOLD MONOLAYER PROTECTED CLUSTERS USING 
NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY 
 
 
Introduction 
History. Gold monolayer protected clusters[1] (AuMPCs), also commonly referred to as 
gold nanoparticles[2], gold nanoclusters[3] or gold colloid[4], are among the oldest[5] 
and most studied metallic-core based particles used in biomedical applications.  Colloidal 
gold is the generation of nanometer-sized gold particles in solution stabilized by salts or 
passivating compounds[6].  In the early 1600s, gold colloids were first described by 
Parcelsus as being formed by the reduction of auric chloride with an alcoholic extract of 
plants[7].  Since then, a multitude of methods for the synthesis of colloidal gold have 
been introduced in literature[8] including the two most popular methods: the Brust-
Schiffrin Method[9] and the Turkevitch reaction[10].  The Turkevitch reaction is the 
most fundamental method of colloidal gold synthesis employing the citrate reduction of 
HAuCl4 in water.  This method allowed the generation of controlled gold nanoclusters – 
nanosized gold particles, stabilized by citrate ions, of pre-chosen size and medial 
stability.  Further investigation into the reaction allowed controlled formation where 
adjusting the ratio between reducing/stabilizing agents would control the AuMPC 
size[11].  The Brust-Schiffrin method pioneered colloid technology by using Faraday’s 
early two-phase system[4] with the use of thiol ligands that strongly bind gold due to the 
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soft character of both gold and sulfur[9].  This method brought considerable impact to the 
colloid field because it proved a simplistic synthesis of thermally stable gold colloids of 
controlled size and dispersity with the ability to be functionalized like stable organic and 
molecular compounds.  Like the Turkevitch reaction, adjusting the thiol to gold mole 
ratios adjust the average gold core sizes.  Here, AuCl4- is transferred to toluene using 
tetractylammonium bromide as the phase-transfer reagent and reduced by NaBH4 in the 
presence of dodecanethiol.  A paradigm shift, Brust et al. augmented their reaction 
protocols to include p-mercaptophenol stabilized gold colloids extending gold colloid 
synthesis to gold colloid functionalization allowing colloid stabilization by a plethora of 
functional thiolated ligands[12].  This breakthrough led to the eventual determination of 
the reactions which describe gold functionalization.  Reported by the Murray group, the 
place exchange reaction describes the replacement of a controlled proportion of 
stabilizing salts or thiols with a variety of functional thiols[13].  With the ability to be 
protected and functionalized by a coat of functional molecules, gold colloids of this form 
were termed gold monolayer-protected clusters[14, 15]. 
 
As a therapeutic, colloidal gold was used in the middle ages to treat a plethora of diseases 
including: heart and venereal ailments, dysentery, epilepsy, tumors and as a diagnostic 
tool for syphilis[16].  Currently, colloidal gold is employed frequently in biological and 
biomedical applications.  Lv et al. investigated trypsin loaded gold nanoparticle 
conjugates by mixing the particles with trypsin in an enzyme appropriate environment 
(pH=8.0)[17].  Following this blending procedure, bonds between the trypsin and gold 
colloid were detected via UV-vis spectroscopy.  In addition, the group evaluated varying 
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protease activity by initiating a comparative-causative study where trypsin protease 
activity was evaluated before and after mixing with the gold nanoparticle solution.  
Improved enzyme activity and stability was detected using a trypsin protease assay.   
 
Current Implementation.  Aside from novel uses of gold colloid to improve current 
experimental methods, a number of groups seek to employ gold colloid in the use of 
cancer diagnostics and therapeutics.  Roa et al. examined the mechanism of glucose-
capped nanoparticle enhanced radiation sensitivity in radiation-resistant human prostate 
cancer cells[18].  These particles enhanced growth inhibition (26.8% decrease in 
proliferation) and decreased cell survival rate (36% decrease at 14 days) in prostate 
cancer carcinoma cell line DU-145 cells.  Even further, using MRC5 human diploid 
fibroblasts, it was found that these particles do not enhance the sensitivity of non-
cancerous cells.  In addition, it was also noted that such particles inhibit proliferation and 
survival by altering the cell cycle distribution through an increase in expression of cyclin 
B1 & cyclin E and a reduction of cyclin A.  In addition to methods seeking to assist in the 
eradication of cancer cells via an endogenously delivered treatment, gold nanoparticles 
are also used as vectors to delivery drugs and other therapeutics.  Prabaharan et al. 
investigated gold nanoparticles stabilized with a monolayer of folate-conjugated 
doxorubicin-poly(ethylene glycol) block copolymer for use as a tumor-targeted drug 
delivery carrier[19].  These particles formed stable unimolecular micelles in aqueous 
solution and were between 24-52 and 10-25 nm in diameter as measured by dynamic 
light scattering and transmission electron microscopy, respectively.  The group found that 
the doxorubicin was released much more rapidly at pH lower (~ pH 5.3-6.6) than pH 7.4 
6 
from micelles that contained folate.  Furthermore, it was observed that folate loaded 
micelle entered cells at a higher rate than unfolated micells due to facilitation by folate-
receptor-mediated-endocytosis thus resulting in high cytotoxity in 4T1 mouse mammary 
carcinoma cell lines.  Overall, it was concluded that such conjugated particles could be 
used for tumor targeted delivery as a vector with pH-triggered drug releasing properties. 
 
Therapeutic Size Constraints.  Such conjugated nanoparticles designed for tumor 
treatment via delivery of some agent must adhere to particular therapeutic size constraints 
– the size therapeutic window.  Generally, the capillary permeability of the endothelial 
barrier in newly vascularized tumors is significantly greater than that of normal 
tissue[20].  Tumor vessels are less permeselective than normal vessels, thought to be due 
to large pores in the vessel wall.  Such transport appears to be limited by diffusion 
through the pores.  Conjugated nanoparticles must extravasate from the tumor vasculature 
while resisting leakage from normal vasculature.  Pegaz et al. described that nanoparticles 
of larger sizes were taken up rapidly by both the mononuclear phagocyte system (MPS) 
and the reticuloendothelial system (RES) components[21].  Ishida et al. determined that 
surface protected liposomes with 120 nm average diameter, which exhibited the most 
prolonged vascular circulation when compared to other particles sizes, showed the 
highest accumulation into all the solid tumors employed in the experiment[22].  
Accumulation of 63 nm liposomes into tumor tissue was comparably lower.  Unezuki et 
al. examined liposomes 63, 133, 198 and 388 nm in average diameter surface protected 
by the ligand poly(ethylene glycol) (PEG)[23].  PEG effectively prolonged circulation 
and decreased liver uptake of liposomes with average diameter of 100 – 200 nm.  
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Diameters larger than 300 nm charted lower circulation times.  PEGylated liposomes of 
the size which showed the most prolonged circulation were accumulated most effectively 
in the murine tumor – particles with average diameters of 137 +/- 38 nm exhibited an 
elevated tumor accumulation.  Thus, nanoparticles of smaller size and longer circulation 
time will have more opportunity to transverse the tumor capillaries[22].  Due to this data, 
it can be concluded that the therapeutic window is between 80-180 nm.  The lower 
threshold of 80 nm is selected to make sure that particles are: below the maximum size of 
tumor vasculature pore size[24], small enough to not be cleared by liver, spleen, RES or 
MPS, and to make sure the particle size is above a level allowing for nanoparticle uptake.  
The upper threshold of 180 nm is selected to ensure that the particle size is small enough 
to ensure tumor vasculature escape.  Therefore particle sizes ranging from 80 – 180 nm 
were chosen with two particle sizes at a maximum and minimum outside the therapeutic 
window (5 nm and 250 nm, respectively).  In order to ensure gold particle stability and 
delivery however, particles must resist the MPS and RES through surface passivation by 
some biological surface modifier. 
 
Poly(ethylene glycol).  One such biological surface modifier is thiolated poly(ethylene 
glycol) (SH-PEG)[25].  It has previously been determined that poly(ethylene glycol) 
ligands conjugate to gold surfaces in a particular conformation.  Poly(ethylene glycol) 
forms two distinctly different molecular conformations when grafted onto lipid 
membranes: “brush” and “mushroom” conformations[26].  The mushroom conformation 
is formed when a low packing density is maintained and conjugate chains are oriented 
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randomly whereas a ~10-fold greater packing density with more extended and weaker 
chain alignment forms the brush conformation.   
 
More importantly, poly(ethylene glycol) is known for its ability to resist the activity of 
the reticuloendothelial system – a system composed of monocytes and macrophages that 
is located near reticular connective tissue such as the spleen[27].  The inherent purpose of 
these cells is for phagocytotic removal of cellular debris, pathogens and foreign 
substances, the intravascular nanoparticles for example, from the bloodstream[28].  For 
example, the attachment of polyethylene-glycol to anti-cancer pharmaceuticals, such as 
interferon-α, is currently used to lengthen the circulation time of these molecules in the 
bloodstream thus reducing the frequency of administration of these drugs thus increasing 
efficacy and patient tolerance[29].  The literature has suggested that photothermal cancer 
therapy based on gold nanoshells, metallodielectric nanoparticles consisting of a 
spherical dielectric core coated with a thin metallic shell, have instituted the use of 
thiolated poly(ethylene glycol) coatings to reduce unwanted protein adhesion under 
targeted local or systemic delivery [30, 31].  Thereafter, surface passivation of these 
nanoparticles using bound thiolated PEG, in concert with conjugated antibodies, assisted 
in maintaining antibody activity in targeted delivery[32, 33].   
 
It can be hypothesized that the efficacy of surface passivation is dependent on the amount 
surface coverage by poly(ethylene glycol).    Quantifying the number of poly(ethylene 
glycol) ligands on the surface – the functionalization efficiency - of gold nanoparticles 
will elucidate the passivation efficacy.  Devising a method to determine the 
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functionalization efficiency of SH-PEG on gold nanoparticles will facilitate future 
determinations for other thiolated functional groups. 
 
Nuclear Magnetic Resonance.  A number of chemical techniques have been instituted in 
order to enumerate the number of molecules on the surface of a nanoparticle.  Nuclear 
magnetic resonance (NMR) spectroscopy is a common technique used in organic and 
medicinal chemistry in order to identify compounds, characterize unknown samples, or 
confirm chemical structures following synthesis[34-36].  NMR helps to identify the 
carbon-hydrogen framework of an organic compound.  In the late 1940s, NMR 
spectroscopy was first developed by physical chemists to study nuclei with different spin 
states[37].  First developed as proton magnetic resonance (1H NMR) in 1951, other 
spectrometers were later developed for 13C NMR, 15N NMR, 19F NMR, 31P NMR and 
other magnetic nuclei.   
 
NMR operates by addressing the energy and number of nuclei in the lower energy α-spin 
state (nuclei aligned with an external magnetic field) and the higher energy β-spin state 
(nuclei aligned with an external magnetic field).  If energetically suitable electromagnetic 
radiation is applied to nuclei that have been oriented by a magnetic field, a nucleus will in 
the α-spin state will absorb the energy, thus flipping its nuclear spin and therefore 
entering the β-spin state.  This absorption of energy is detected and output as a signal in 
the NMR spectrum.  The excited molecules return from their state of resonance, due to 
their alignment as a result of the impingement of electromagnetic radiation, and release 
their energy as heat. 
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In order to use NMR as quantitative technique, spectroscopists and chemists alike 
instituted the use of spectrum peak integration[38].  The extensive use of integration in 
1H NMR arises from the renowned doctrine that “the area of an NMR resonance is 
proportional to the relative number of nuclei giving rise to it.”  During data processing, a 
number of precautions must be taken to ensure the acquired data accurately reflects the 
relative ratios in the sample used to achieve precise integration.  The signal to noise ratio 
must be optimized as well as the sensitivity and effective digitalization of the data.  
Careful phasing and removal of baseline distortions are essential for accurate integration.  
Although routine use of 1H NMR integration yields only 10-20% accuracy[39], its use is 
paramount in the field of quantifying ligands conjugated to gold nanoparticles - following 
decomposition allowing desorption of the ligands[40]. 
 
Previous Ligand Enumeration Strategies. A number of previous endeavors at quantifying 
the number of ligands on the surface of gold nanoparticles with respect to particle size 
have been conducted.  Hurst and Lytton-Jean et al. investigated the parameters that 
influence coverage on gold nanoparticles[41].  Evaluating the effects of salt 
concentration, spacer composition, nanoparticle size, and degree of sonication, maximum 
loading was obtained by salt aging the nanoparticles in the presence of DNA containing a 
PEG spacing in ~0.7 M NaCl.  In order to quantify the surface loading of DNA on the 
gold nanoparticles, oligonucleotides were labeled with a fluorescent tag - 6’FAM3’ – and 
quantified by comparing the ligand concentration (found by fluorescence) and the gold 
concentration (found by UV-Visible spectroscopy).  Larger nanoparticles (250 nm) were  
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Figure 1. Functionalization strategy for PEGylation of gold monolayer protected 
clusters.  Illustrated above are thiolated poly(ethylene glycol), stock unconjugated 
gold nanoparticles and PEGylated gold monolayer protected clusters. 
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found to have orders of magnitude higher DNA loading than smaller (13-30 nm) 
nanoparticles thought to be due to their larger surface area.  Other groups have used 
fluorescence as the primary source of ligand quantification.  Other groups used lactose 
molecules, labeled to the distal ends of the PEG ligands, and thermogravimetric analysis 
(TGA)[42].  Using the TGA, the weight decrease of PEG due to its thermal 
decomposition was determined.  The number of PEG chains on each gold particle was 
calculated by using the concentration of gold particles provided by the manufacture and 
the weight loss measured by the TGA. 
 
The use of NMR alone as a quantification tool following liberation of ligands from the 
particle does not require the use of surface-density altering ligands nor does it require the 
thermal or chemical decomposition of a large quantity of precious sample.  Other 
methods of enumerating the number of ligands attached to AuMPCs use fluorescently 
tagged or labeled PEG agents which affect the packing of those ligands or involve 
protocols which require the destruction of high quantities of sample.  Here, we both 
enumerate the number of PEG ligands on the surface using a “label-free,” NMR based 
method and characterize the loading capacity over a small range of particle sizes.  We 
will also compare the findings from the NMR measurements against predicted 
considerations.  From this, we will glean information regarding the functionalization 
efficiency of PEG to AuMPCs with respect to particle size and surface area.  Thereafter, 
we will examine how PEG ligands are concentrated or packed onto the surface of varying 
sizes of AuMPCs.  Such knowledge will enable a deeper insight into the efficacy of 
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nanotechnology as it is related to and possibly governed by the functionalization 
efficiency of its individual technological apparatus. 
14 
Materials and Methods 
Nanomaterials.  Unconjugated AuMPCs 5, 80, 100, 150, and 250 nm in diameter were 
obtained from TedPella, Inc. (Redding, CA).  Lyophilized SH-PEG (5,000 MW) was 
obtained from Laysan Bio, Inc. (Arab, AL).  MilliQ® grade (Millipore Corporation, 
Billerica, MA) deionizied water (DI H2O), obtained using a MilliQ® Academic System 
outfitted with a Quantum® EX Ultrapure Organex Cartridge, was used throughout all 
experimental phases.   
 
Instrumentation and Assays.  Absorbance measurements of AuMPCs were collected 
using a Varian Cary 5000 UV-VIS-NIR spectrophotometer (Varian, Inc., Palo Alto, CA).  
Particle diameter measurements were obtained using a Malvern Zetasizer Nano ZS 
dynamic light scattering based system (Malvern Instruments, Westborough, MA).  NMR 
measurements were obtained using a 400 Hz instrument equipped with a 9.4 Tesla 
Oxford magnet which is controlled by a Bruker AV-400 console. 
 
Predicted Loading Capacity.  For analytical comparison with results from NMR, the 
predicted loading capacity was calculated.  It was assumed that AuMPCs form spherical 
clusters and follow the fundamental surface area formulae, SA=4πr2.  In addition, it was 
assumed that SH-PEG adsorbs onto AuMPCs assuming the brush conformation as 
discussed by Wuelfing et al [1].  The brush conformation of SH-PEG occupies a 
molecular surface area footprint of 0.35 nm2.  The maximum number of SH-PEG ligands 
per AuMPC was calculated by dividing the total surface area of a spherical AuMPC by 
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the SH-PEG molecular footprint.  The maximum number of SH-PEG ligands per AuMPC 
was determined for each particle size. 
 
Place Exchange Reaction.  A clear 20 mM solution of SH-PEG was generated by adding 
lyophilized SH-PEG to DI H2O at room temperature.  Unconjugated AuMPCs at their 
stock concentration were vortexed, to ensure even suspension in solution, and added to 
the SH-PEG solution at a 1:1 volumetric ratio.  Following a slow overnight stir, using a 
miniature magnetic stirring bar and stir plate thus allowing sufficient time for maximal 
functionalization, free citrate and unconjugated SH-PEG ligands were removed using 
Thermo Fisher Scientific Inc. Slide-A-Lyzer® osmotic dialysis cassettes with a 
membrane molecular weight cutoff of 10,000 MW.  PEGylated AuMPCs (PEG-S-
AuMPCs) were harvested from the cassettes and stored at 5°C.  Three conjugation trials 
(n=3) were performed for each particle size to assess the variability of the conjugation 
protocol. 
 
Determination of Unknown AuMPC Concentrations.  Following conjugation and osmotic 
dialysis, the resultant AuMPC concentration is unknown.  In order to determine unknown 
concentrations, absorbance vs. known concentration standard curves were generated for 
each particle size using stock AuMPC solutions and UV-VIS instrumentation.  From the 
generation of the standard curves, both the molar extinction coefficient (ε) and the 
absorbance maximums (λ) were determined for each particle size. The absorbance values 
of conjugated AuMPC solutions of unknown concentration were then related to the 
standard curves using Beer’s law (A=εlc) to determine the subsequent concentration. 
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Conjugation Confirmation.  Following the place exchange reaction, SH-PEG conjugation 
was confirmed by monitoring the diameter of the AuMPCs with dynamic light scattering.  
Stock solutions of the unconjugated AuMPCs were used as size controls for each particle 
diameter.  Each conjugation trial for each particle diameter was evaluated to assess the 
variability of diameter increase due to the execution of the conjugation protocol.  
Following a strict protocol, particles were removed from the 5°C storage environment, 
allowed to warm to room temperature and vortexed for a minimum of five seconds to 
ensure colloidal resuspension.  1 ml of each conjugation trial was loaded into a low 
volume disposable cassette.  Prior to measurement initialization, each cuvette was tilted 
back and forth three times to ensure colloidal resuspension.  Typical count rates were 
between 100 and 350 kcps.  Size-distribution profiles and average radii for each 
conjugation trial were obtained as the mean of triplicate measurements.  Each conjugate 
trial average diameter was statistically compared against the unconjugated control 
diameter using the Paired t-test. 
 
Quantification of Functionalized Conjugates.  The number of poly(ethylene glycol) 
ligands conjugated to the surface of each AuMPC was quantified using nuclear magnetic 
resonance via a 400 MHz instrument equipped with a 9.4 Tesla Oxford magnet controlled 
by a Bruker AV-400 console.  The main NMR probe for the instrument is a 5 mm Z-
gradient broadband inverse (BBI) probe with automatic tuning and matching capability 
(ATM).   
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Samples of each conjugation trial for each particle size were obtained and equalized to a 
concentration of 49 μM at a volume of 500 μl.  Each sample was placed into a Wilmad 
LabGlass (Vineland, NJ) 5MM Thin Wall, 7” Length, 500 MHz NMR tube.  In order to 
quantify the number of ligands on the surface of the gold nanoparticles using NMR, the 
ligands must be removed from the surface of the nanoparticle.  In order to achieve this 
removal, one to two large iodine (I2) crystals were added to each tube.  Chemically, the 
iodine has a higher affinity for the gold than the sulfur molecules [43].  Due to this 
difference in affinity, the iodine decomposes the AuMPCs where the SH-PEG molecules 
are released into solution.  The place-exchange reaction of thiol for iodine to the gold 
clusters causes destabilization causing the iodinated gold to fall out of solution [44].  
Typically, when thiolated ligands desorb from gold particles, they form disulfide bonds 
[14].  In addition, iodine decomposition was allowed to occur to completion for one hour 
as previously described [40] prior to spectrum measurement.  In order for the NMR to 
“lock” onto each sample, each tube was spiked with 50 μl of D2O.   
 
In order to ensure a spectrum of the decomposed gold and emancipated ligands could be 
acquired, a pre-saturation technique was employed to suppress the enormous peak 
typically generated by H2O. This allowed ample visualization of the more subtle peaks in 
the resulting spectrum. Each sample was measured following the same major parameters.  
The number of scans and receiver gain was held to 32.  For the f1 channel, P0 and P1 
were both held to 11.38 μs.  One spectrum was collected per sample to ensure the 
occurrence of conjugate desorption. 
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In order to quantify the concentration of desorbed conjugates, the pre-saturation 
technique cannot be employed due to its inherent modulation of the spectrum baseline.  
Such modulation introduces error into any integral based quantification strategies.  
Therefore, a more common “zg30” program was used to acquire a spectrum without 
using a presaturation pulse.  The number of scans was set to 16 whereas the receiver gain 
was held to 4.  A delay (D1) of 10 seconds was added between scans thus ensuring a 
large enough relaxation time to minimize the effect of the H2O peak on more subtle 
peaks. For the f1 channel, P1 was held to 11.38 μs.  One spectrum was acquired per 
sample and integration was used enumerate the ratio between the PEG chain terminal 
group, CH3-, peak and the disulfide, PEG-S-S-PEG, bond triplet peaks.  Prior to any 
integration, all spectra were baseline corrected to zero using automatic and manual 
processes. 
 
A serial dilution was also performed in order to generate a standard curve relating 
concentration to integral-ratio.  In order to generate such integral-ratio values, the PEG 
terminal CH3- peak for a concentration of 20 mM SH-PEG was directly compared to the 
CH3- peaks of samples containing lower concentrations of SH-PEG.  This comparison 
was achieved via spectral summation of the 20 mM SH-PEG and a ppm shifted spectra 
containing a lower conjugate concentration (APPENDIX C).  Integration was used in 
order to determine the integral-ratio between the 20 mM sample peak and the lower 
concentration peak.  A standard curve is then generated from integral-ratios of all 
samples in comparison to the 20 mM peak. 
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Desorbed-conjugate spectrums containing CH3- peaks are then compared to the 20 mM 
SH-PEG CH3- peak generating an integral-ratio.  This integral ratio can be used to 
quantify the concentration of PEG ligands in the desorbed-conjugate sample.  Using the 
integral-ratio between the CH3- peaks and the triplet disulfide (PEG-S-S-PEG) peaks, the 
number of S-PEG ligands that desorbed from the gold colloid can be quantified.  Figure 2 
describes the entire NMR spectral analysis protocol in a flow chart format. 
 
Statistical Analysis.  Statistical Analysis was conducted using SigmaStat software.  
Paired t-tests for conjugation confirmation were conducted with a confidence interval of 
99%.  Paired t-tests for conjugate quantification were conducted with a confidence 
interval of 95%. 
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Figure 2.  NMR spectral analysis protocol for the quantification of conjugated 
ligands depicted in flow chart format. 
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Results 
Determination of Unknown AuMPC Concentration.  In order to determine the AuMPC 
concentration following particle purification, the absorbance was obtained by monitoring 
the UV-Vis spectra of each unconjugated particle size (Figure 3).  Standard absorbance-
concentration curves were generated (Figure 4).  The molar extinction coefficient was 
determined in accordance with Beer’s law.  The absorbance maxima (λ in mm) and molar 
extinction coefficients (ε in Lmol-1cm-1) are shown in Table 1.  Following particle 
purification, the resultant concentrations were determined via Beer’s law at the maximum 
absorbance wavelength for each particle size (Figure 5). 
 
Conjugation Confirmation.  Particle conjugation was assessed by monitoring the 
hydrodynamic radii of each conjugation trial.  Used as a quantitative technique for 
qualitative assessment, significant diameter increases was used to infer successful 
conjugation.  Dynamic light scattering (DLS) results are shown in Figure 6.  DLS 
correctly sized unconjugated particle sizes.  The size increase of the AuMPCs following 
PEGylation was also monitored using DLS.  This size increase, presumably representing 
the radial thickness of the conjugated PEG coat, was significant for each particle diameter 
except 5 nm. 
  
Quantification of Functionalized Conjugates.  Conjugated PEG-S ligands were quantified 
using nuclear magnetic resonance spectroscopy.  Integral ratios between peaks were 
acquired and analyzed in Bruker’s TopSpin program.  All non pre-saturated PEG-S-
AuMPC spectra depicting integral ratios used in this work are shown in APPENDIX B. 
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Figure 3. Absorbance as a function of wavelength for each stock nanoparticle 
solution over the UV-Vis range. 
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Figure 4. Standard absorbance-concentration curves generated from the 
absorbance spectroscopy of serial dilutions of unconjugated particles.  These 
standard curves were used to determine the molar extinction coefficient following 
the linearity of Beer’s Law (A=εlc).  This data is eventually used for the calculation 
of unknown particle concentrations. 
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Diameter (nm) Abs Max λ (nm) Mol Ext. ε (L/(mol*cm))
5 515 1876.1
80 543 3379.2
100 568 2585.3
150 661 1441.7
250 605 822.48
PEG-S-AuMPC Particle Characteristics
Absorbance Spectroscopy
 
 
Table 1.  PEGylated gold monolayer protected cluster characteristics.  This table 
includes the absorbance maxima and molar extinction coefficients used to calculate 
unknown particle concentrations following purification.
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Figure 5.  Absorbance of each PEGylated nanoparticle conjugation trial  obtained 
by monitoring the UV-Vis spectra of each conjugated particle size.  Trials 1, 2, and 3 
top to bottom, respectively. 
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Figure 6. Particle conjugation was assessed by monitoring the difference between 
the hydrodynamic radii of conjugated and stock solutions of AuMPC using dynamic 
light scattering.  Bar heights represent the mean of three experiments with error 
bars shown as the standard deviation *Significant size increase for p<0.01 using 
Paired T-Test. 
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Figure 7.  Diameter increase of AuMPCs following PEGylation determined by 
monitoring the hydrodynamic radii of each conjugation trial using dynamic light 
scattering.  This size increase represents the radial thickness of the PEG coat.  Data 
points represent the mean of triplicate experiments with error bars shown as the 
standard deviation. *Significant difference between size increase per data point for 
p<0.01 using Paired T-Test. 
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A serial dilution was used to create a standard curve relating integral ratio to 
concentration.  A coefficient of determination (R2) value larger than 0.9 was used as a 
cutoff value for acceptable linear congruency.  The linear fit with R2 value and resulting 
equation is shown in Figure 8.  A R2 value of 0.9172 confirms proof of concept for NMR 
as a quantitative technique to concentrations as low as 0.363 mM.  All acquired and 
analyzed PEG-SH serial dilutions used in this work are shown in APPENDIX A. 
 
As a further proof of concept, the difference in spectral response between PEG-SH and 
decomposed PEG-S-AuMPC samples was evaluated using pre-saturation to remove the 
background H2O proton peak and reveal the ligand peaks.  An example of the spectral 
distinctions between PEG-SH protons and liberated PEG-S-S-PEG protons is shown in 
Figure 9.  The appearance of triplet peaks in the sulfide region suggests the expected 
formation of disulfide bonded liberated ligands.  
 
In order to obtain quantifiable spectra, the pre-saturation technique can not be used due to 
its inherent modulation of the spectrum baseline.  Non pre-saturated spectra were 
obtained and analyzed.  A sample analyzed spectrum is shown in Figure 10 whereas other 
spectra are shown in APPENDIX B.  The CH3- proton peak occurring at ~3.3 ppm 
represents the distal moiety at the end of the PEG polymer chain thus depicting a single 
S-PEG ligand.  The triplet peak occurring between 2.8-2.9 ppm represents the disulfide 
bond between two sulfur atoms of two S-PEG ligands.  In a similar fashion, the CH3-  
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Figure 8. NMR integral ratio calibration as a function of poly(ethylene glycol) 
concentration as a proof of concept.  A serial dilution was used to create a standard 
curve relating integral ratio to concentration.  A R2 value of 0.9172 demonstrates a 
proof of concept where NMR can be used as quantitative technique to measure 
poly(ethylene glycol) concentrations as low as 0.363 mM (vertical dotted line). 
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Figure 9. An example of the spectral distinctions between PEG-SH protons and 
liberated PEG-S-S-PEG protons.  Top: 20 mM 5000 MW PEG.  Bottom: 
Decomposed PEG-S-AuMPCs.  The appearance of triplet peaks in the sulfide region 
(~2.8-2.9 ppm) following AuMPC decomposition suggests the expected formation of 
sulfide bonded PEG to gold from the disulfide bonded reagents. 
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Figure 10.  Sample NMR spectra of decomposed PEGylated gold monolayer 
protected clusters without using pre-saturation protocol.  The CH3- proton peak 
occurring at ~3.3 ppm represents the distal moiety at the end of the PEG polymer 
chain thus representing a single S-PEG ligand.  The triplet peak occurring between 
2.8-2.9 ppm represents the disulfide bond between two sulfur atoms of two S-PEG 
ligands. 
 
 
~3.3 ppm distal CH3 peak 
~ PEG-S-S-PEG triplet peak 
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peak to disulfide triplet peak integral-ratios were uploaded into Microsoft Excel.  A 20 
mM SH-PEG CH3- peak was also compared to each liberated PEG-S-S-PEG CH3- peak 
generating an integral-ratio in order to quantify the concentration of PEG in each sample.  
Comparing the concentration of PEG in each sample to the CH3- peak to disulfide 
integral-ratio, the concentration of PEG-S-S-PEG in each sample can be calculated.  The 
number of ligands per particle can be calculated by dividing the desorbed PEG-S-S-PEG 
concentration (ligands/volume of sample) by the AuMPC particle concentration (AuMPC 
particles/volume of sample) and multiplying by 2 - accounting for the dimeric nature of 
the desorbed PEG.  The number of ligands per particle and the number of ligands per 
particle surface area are shown in Figure 11.  Statistical significance between sample 
points is depicted in each figure.  Predictive calculations of ligands per AuMPC and 
ligands with respect to total AuMPC surface area are shown superimposed in Figure 11 
and shown in Figure 13. 
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NMR
Predicted
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 11. Conjugated ligand enumeration (NMR).  Top: number of ligands per 
particle as a function of particle surface area.  Bottom: number of ligands per 
particle areas a function of particle diameter.  Significant size increase for p<0.05 
using Paired T-Test was not observed. 
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Discussion 
Studying the functionalization efficiency with respect to particle size was the overarching 
purpose of this work.  In our initial assessment, we hypothesized that the molecular 
footprint of PEG on the surface of gold was constant, but unknown, especially as a 
function of substrate dimensions.  Wuefling et al. estimated that the PEG-SH ligand 
footprint, the area occupied by the ligand on the surface of 2.8 nm gold particles, was 
0.35 nm2 [1].  Accordingly, we hypothesized that this ligand footprint was constant 
across a range of particle sizes in a defect-free packing arrangement.  Predicted trends 
calculated based on Wueling et al. and extended to larger particle diameters are shown in 
Figure 13.  
 
The number of ligands per particle and the number of ligands per particle surface area 
were calculated from experimental measurements, thus elucidating both ligand 
enumeration per particle and the surface packing of PEG on gold over a range of particle 
sizes.  Ligand enumeration is shown in Figure 11.  The number of ligands per particle via 
NMR increases with increasing particle size suggesting that the ligand loading of 
particles increases with available surface area.  Comparison with the equivalent data 
predicted as an extrapolation from Wuefling et al. reveals similar trends with an absolute 
quantitative offset ranging from three to five orders of magnitude.   This large deviation 
between predicted and actual data is consistent with the superposition of approximately 1 
x 103 free (unconjugated) PEG ligands in the sample per particle and an increased relative 
ligand packing efficiency for particle diameters greater than the 2.8 nm used in the 
Wuefling et al. study. 
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Evidence for particle size-dependent ligand packing appears as Figure 12. Based on 
NMR data collected in this work, the number of ligands per particle surface area (ligand 
packing density) increases as the particle diameter increases.  Ligand packing on large 
(from a molecular perspective), flat surfaces is unconstrained by curvature effects that 
may influence molecular interactions at the nanoscale.  The PEG footprint reported by 
Wuefling et al. was estimated from association with AuMPC having a 2.8 nm diameter.  
Relief from nanoscale-induced packing constraints should be evident as the substrate 
dimensions become large relative to the molecular footprint of the ligand.  The PEG 
ligand footprint of 0.35 nm2 estimated by Wuefling et al. was obtained on particles with a 
surface area of 24.6 nm2.  Particle surface areas in this work range from 78.5 nm2 to 2 x 
105 nm2 with the largest areas corresponding to the greatest difference in comparison 
with Wuefling et al..  This finding is consistent with the speculation of ligand packing 
constraint due to defects induced by nanoscale surface characteristics.  Small molecular 
differences can have a profound effect on measured ligand packing density.  Levin et al. 
report that that the molecular footprint of a PEG similar to the one used here, but 
modified to contain a fluorescein molecule, is 10.8 nm2 on a 90 nm diameter AuMPC.  
While it is difficult to assess the relative contributions of substrate dimensions and 
molecular modifications of the ligand footprint, the value reported by Levin et al. is more 
than 30-fold greater than that by Wuefling et al.  In any case, it is clear that the molecular 
packing density of ligand is reduced as substrate diameter decreases over the range from 
250 nm to 5 nm diameter particles (Figure 12).  The absolute value of ligand surface 
concentration should be assessed by an alternate technique to characterize potential 
36 
contributions due to the presence of unconjugated free ligand, NMR calibration and/or 
quantitation deficiencies or other factors.  
 
Monitoring of the absorbance of each particle size yielded five distinct SPR curves 
shown in Figure 3.  In addition, each resonance curve had distinct absorbance maximums 
allowing for the computation of particle concentrations.  The surface plasmon resonance 
curve profile of each particle size across each conjugation trial remained constant 
showing no SPR changes between conjugation trials following functionalization (Figure 
5).  Gold concentrations across replicate conjugation trials were found to be in the same 
order of magnitude suggesting success of the method at determining the unknown PEG-
S-AuMPC concentration. 
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Figure 12.  Surface packing of PEG on AuMPC as a function of particle surface 
area as quantified using NMR.  Surface packing is defined as the number of PEG 
ligands per particle surface area.  Data points represent the mean of three 
independent experiments with error bars as standard deviations.  *Significant size 
increase for p<0.05 using Paired T-Test. 
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Figure 13.  Predicted loading capacity of AuMPCs by SH-PEG.  The Wuefling et al. 
estimation that the PEG-SH ligand footprint, the area occupied by the ligand on the 
surface of 2.8 nm gold particles, was 0.35 nm2 was used to generate these estimates 
for AuMPC of greater diameter by extrapolation. 
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Particle conjugation was assessed using DLS.  A significant increase in the 
hydrodynamic radii of the particles in solution was used to confirm conjugation.  
Unconjugated particle sizes 5, 80, 100, 150 and 250 nm in size were accurately measured 
by the DLS.  Conjugated particles were measured and gold particles 80, 100, 150 and 250 
nm in diameter were shown to significantly increase in size.  The size increase was fully 
apparent in the 5 nm gold particles; however, the large standard deviation between 
conjugation trials lead to a statistical indifference.  It can be ascertained that this large 
deviation could be due the agglomeration of unconjugated particles prior to 
functionalization[46] or the fact that the 5 nm particle size is near the detection limit of 
the instrument.  A quantitative technique in this regard, DLS data was used to elucidate 
PEG layer thickness.  Determination of the size increase of the AuMPCs following 
conjugation elucidates the radial thickness of the affixed PEG layer.  This data, coupled 
with the approximate length of an individual PEG ligand, will provide some insight into 
the conformation of the PEG conjugates on the surface of AuMPCs.  Such speculation 
will be confirmed in concert with the addition of the corroborative ligand enumerative 
strategy, ICP-AES. 
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CHAPTER III 
 
Manuscript: INDUCTIVELY COUPLED PLASMA ATOMIC EMISSION 
SPECTROSCOPY AS A NEW TOOL FOR QUANTIFICATION OF THIOLATED 
CONJUGATES BOUND TO GOLD NANOPARTICLES 
 
 
Introduction 
History.  Gold monolayer protected clusters[1] (AuMPCs), also commonly recognized as 
gold nanoparticles[2], gold nanoclusters[3] or gold colloid[4], are among the oldest[5] 
and most studied metallic-core based particles used in biomedical applications.  Colloidal 
gold is the formation of nanometer-sized gold particles in solution stabilized by salts or 
passivating compounds[6].  A number of methods for the formation of colloidal gold 
have been introduced in literature[8] including the two most popular methods: the Brust-
Schiffrin Method[9] and the Turkevitch reaction[10].  The Brust-Schiffrin method 
pioneered colloid technology by using Faraday’s early two-phase system[4] with the use 
of thiol ligands that strongly bind gold due to the soft character of both gold and 
sulfur[9].   
 
Recognizing their ability to actively change the surface properties of gold colloid, Brust 
et al. augmented their reaction protocols to include p-mercaptophenol stabilized gold 
colloids, thus extending gold colloid synthesis to gold colloid functionalization allowing 
colloid stabilization by a plethora of functional thiolated ligands[12].  This advancement 
in colloid technology led to the eventual determination of the reactions which describe 
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gold functionalization.  Described by the Murray group, the place exchange reaction 
describes the replacement of a controlled proportion of stabilizing salts or thiols with a 
variety of functional thiols[13].  With the ability to be protected and functionalized by a 
layer of functional molecules, gold colloids of this form were phrased gold monolayer-
protected clusters[14, 15]. 
 
Poly(ethylene glycol).  One such surface modifier used to functionalize colloidal gold is 
thiolated polyethylene glycol (SH-PEG)[25].  It can be assumed that polyethylene glycol 
ligands conjugate to gold surfaces in a particular conformation.  Comparably, 
polyethylene glycol forms two distinctly different molecular conformations when grafted 
onto lipid membranes: “brush” and “mushroom” conformations[26].  The mushroom 
conformation is formed when a low packing density is maintained and ligand chains are 
oriented randomly.  Contrarily, a ~10-fold greater packing density with a more extended 
and weaker chain alignment forms the brush conformation.   
 
Moreover, polyethylene glycol is known for its ability to resist the activity of the 
reticuloendothelial system.  This innate biological defense mechanism is a system 
composed of monocytes and macrophages that is located near reticular connective tissue 
such as the spleen[27].  The inherent purpose of these cells is for phagocytosing and 
removing cellular debris, pathogens and foreign substances, the intravascular 
nanoparticles for example, from the bloodstream[28].  A surface passivant, PEG is used 
throughout medical literature to thwart the activity of the RES.  For instance, the 
attachment of PEG to oncological pharmaceuticals, such as interferon-α, is currently used 
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to lengthen the circulation time of these molecules in the bloodstream [29]. This reduces 
the frequency of administration of these drugs thus increasing therapeutic efficacy and 
patient tolerance.  In addition, PEG has been used with gold nanoshells - 
metallodielectric nanoparticles consisting of a spherical dielectric core coated with a thin 
metallic shell.  Used in photothermal cancer therapy, gold nanoshells can be loaded with 
thiolated polyethylene glycol coatings to reduce unwanted protein adhesion under 
targeted local or systemic delivery [30, 31].  Thereafter, surface passivation of these 
nanoparticles using bound thiolated PEG, in concert with conjugated antibodies, assisted 
in maintaining antibody activity in targeted delivery[32, 33].   
 
It can be hypothesized that the efficacy of surface passivation is dependent on the amount 
surface coverage by polyethylene glycol.    Quantifying the number of polyethylene 
glycol ligands on the surface – the functionalization efficiency - of gold nanoparticles 
will elucidate the passivation efficacy.  Devising a method to determine the 
functionalization efficiency of SH-PEG on gold nanoparticles will facilitate future 
quantification for other thiolated functional groups. 
 
Nuclear Magnetic Resonance.  A number of analytical techniques have been instituted in 
order to enumerate the number of conjugated molecules on the surface of a nanoparticle.  
Used in organic and medicinal chemistry, Nuclear magnetic resonance (NMR) 
spectroscopy is a common technique used in order to identify compounds, characterize 
unknown samples, or confirm chemical structures following synthesis[34-36].  NMR 
helps to identify the carbon-hydrogen framework of an organic compound.  
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Spectroscopists instituted the use of spectrum peak integration in order to use NMR as a 
quantitative technique [38].  The extensive use of integration in 1H NMR arises from the 
renowned doctrine that “the area of an NMR resonance is proportional to the relative 
number of nuclei giving rise to it.” Although routine use of 1H NMR integration yields 
only 10-20% accuracy[39], its use is paramount in the field of quantifying ligands 
conjugated to gold nanoparticles - following decomposition allowing desorption of the 
ligands[40]. 
 
Previous Ligand Enumeration Strategies. A number of previous endeavors at quantifying 
the number of ligands on the surface of gold nanoparticles with respect to particle size 
have been conducted.  Hurst and Lytton-Jean et al. investigated the parameters that 
influence coverage on gold nanoparticles[41].  Analytically evaluating the effects of salt 
concentration, spacer composition, nanoparticle size, and degree of sonication, maximum 
loading was obtained by salt aging the nanoparticles in the presence of DNA containing a 
PEG spacing in ~0.7 M NaCl.  To quantify the surface loading of DNA on the gold 
colloid, oligonucleotides were labeled with a fluorescent tag - 6’FAM3’ – and quantified 
by comparing the ligand concentration (measured by fluorescence) and the gold 
concentration (determined by UV-Visible spectroscopy).  As a result, larger nanoparticles 
(250 nm) were found to have orders of magnitude higher DNA loading than smaller (13-
30 nm) nanoparticles.  This disparity was thought to be due to their larger surface area.  
Other groups have used fluorescence as the primary source of ligand quantification.  Other 
groups used lactose molecules, labeled to the distal ends of the PEG ligands, and 
thermogravimetric analysis (TGA)[42].  Using the TGA, the weight decrease of PEG, due 
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to its thermal decomposition, was measured.  The number of PEG chains on each gold 
particle was calculated by using the concentration of gold particles and the weight loss 
measured by the TGA.   
 
Although all studies seeking to quantify the loading of their gold particles were 
successful, here, we aim to quantify the number of PEG ligands on the surface of our 
AuMPCs using only “label-free” methods which will not affect surface loading or require 
decomposition of a significant amount of sample.   
 
ICP-AES.  Inductively coupled plasma atomic emission spectroscopy (ICP-AES), also 
referred to as inductively coupled plasma optical emission spectroscopy (ICP-OES), is an 
analytical technique normally used to assist in the detection of trace metals in collected or 
synthesized samples [47, 48].  Using a stream of inductively coupled plasma[49], a 
plasma source supplied energetically by electrical currents which are produced by time 
varying magnetic fields, excited atoms are generated that emit electromagnetic radiation 
at wavelengths characteristics of that element.  The intensity of the emission of 
electromagnetic radiation is quantitatively correlated with the concentration of each 
element in the sample. 
 
There are a number of applications of current use for ICP-AES in the field of biomedical 
engineering.  Karami and Rostami-Ostadkalayeh used ICP-AES during their investigation 
into the synthesis of iron nanoclusters with more porous structure using a pulsed current 
electrochemical method[50].  In this study ICP-AES was used for bulk analysis of the 
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optimum iron nanocluster samples.  Revealing elemental composition with more 
precision than X-ray diffraction (XRD) and energy-dispersive X-ray spectroscopy (EDX) 
measurements, ICP-AES was used to confirm that the silver composition of each sample 
was lower than 0.01 %wt, thus negligible. XRD and EDX were also used, however, this 
silver impurity was not detected due to the fact that the silver was located at the center of 
each iron nanoparticle (silver is the starting agent for crystallization). Concordantly, Zhu 
et al. investigated aerobic oxidation by immobilized gold nanoparticles and used ICP-
AES to measure the gold content of the gold immobilized silica mesostructure 
samples[51].  As a further example, Fischer et al. employed ICP-AES in order to 
determine in vivo nanoparticle kinetics and distribution using a non-isotopic 
quantification method [52].  The authors concluded that ICP-AES was an effective 
method for detecting CdSe/ZnS quantum dots and gold nanoparticles in biological tissue 
because the elemental detection sensitivity of the instrument, in moles of particles per 
gram, was at a suitable limit.  One limitation discovered was that ICP-AES could not 
detect Fe3O4 nanoparticles effectively in these biological samples.  The authors attributed 
this limitation to the presence of natural Fe2+ in tissues, thus illustrating the fact that the 
technique should not be utilized for measuring nanoparticles or biomaterials composed of 
endogenous elements. 
More specifically, concerning the mechanism by which the ICP-AES measures the 
atomic concentration, when a sample in aerosol form enters the central channel of the 
inductively coupled plasma, a number of specific events occur[53].  The sample 
dissolves, the matrix breaks down and the resulting analyte and solvent vapor undergo 
excitation to produce atomic and ionic species in various energy states.  Some of this 
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energy is released as electromagnetic radiation at a wavelength which is characteristic of 
the emitting atom or molecule. Elemental concentrations determined by the intensity of 
the element’s electromagnetic radiation, as compared to an elemental standard curve, are 
obtained from ICP-AES in mg/L.  Using the elemental concentration of sulfur and gold 
and basic stoichiometry, one can calculate the number of sulfur atoms per gold 
nanoparticle, thus quantifying the number of PEG ligands on the AuMPC-PEG constructs 
studies in this work.   
More advantageous than other forms used in literature as a quantification technique, ICP-
AES does not require the use of surface-density altering ligands nor does it require the 
thermal or chemical decomposition of a large quantity of sample.  Other methods of 
enumerating the number of ligands attached to AuMPCs use fluorescently tagged or 
labeled PEG agents which may affect the packing of those ligands or involve protocols 
which require the destruction of large quantities of material.  Here, we both enumerate 
the number of PEG ligands on the surface using a “label-free,” ICP-AES based method 
and characterize the loading capacity over a range of nanoparticle sizes.  We will also 
compare the findings from the ICP-AES measurements against predicted considerations.  
As in the NMR study, here we will also obtain information regarding the 
functionalization efficiency of PEG on AuMPCs with respect to particle size and surface 
area.  Thereafter, we will examine how PEG ligands are concentrated or packed onto the 
surface of varying sizes of AuMPCs.  Such knowledge will enable a deeper insight into 
the efficacy of nanotechnology as it is related to and possibly governed by the 
functionalization efficiency of its individual technological apparatus. 
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Materials and Methods 
Nanomaterials.  Unconjugated AuMPCs 80, 100, 150 nm in diameter were acquired from 
TedPella, Inc. (Redding, CA).  Lyophilized SH-PEG (5,000 MW) was purchased from 
Laysan Bio, Inc. (Arab, AL).  70% HNO3 (Nitric Acid), and both 1000 mg/L Gold in 
10% HCl and 1000 mg/L Sulfur in H2O ICP-AES element calibration standards were 
purchased from Thermo Fisher Scientific, Inc. (Waltham, MA).  MilliQ® grade 
(Millipore Corporation, Billerica, MA) deionizied water (DI H2O), obtained using a 
MilliQ® Academic System outfitted with a Quantum® EX Ultrapure Organex Cartridge, 
was utilized throughout all experimental phases.   
 
Instrumentation and Assays.  Absorbance measurements of AuMPCs were gathered using 
a Varian Cary 5000 UV-VIS-NIR spectrophotometer (Varian, Inc., Palo Alto, CA).  
Particle diameter measurements were acquired using a Malvern Zetasizer Nano ZS 
dynamic light scattering based system (Malvern Instruments, Westborough, MA).  
Baseline SH-PEG concentrations following osmotic dialysis were obtained using the 
Measure-iT™ Thiol Assay Kit (Invitrogen Corporation, Carlsbad, CA) and the Perkin 
Elmer LS 50 B Luminescence Spectrometer.  NMR measurements were acquired using a 
400 Hz instrument equipped with a 9.4 Tesla Oxford magnet which is controlled by a 
Bruker AV-400 console.  ICP-AES measurements were collected using a Varian 720-ES 
Inductively-coupled Plasma Atomic Emissions Spectrometer (ICP-AES). 
 
Predicted Loading Capacity.  For analytical comparison with results from ICP-AES 
measurements, the predicted loading capacity was calculated.  It was assumed that 
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AuMPCs form spherical clusters and follow the fundamental surface area formulae, 
SA=4πr2.  In addition, it was assumed that SH-PEG ligands adsorb onto AuMPCs 
assuming the Brush conformation as discussed by Wuelfing et al [1].  The Brush 
conformation of SH-PEG occupies a molecular surface area footprint of 0.35 nm2 on 
colloidal gold.  The maximum number of SH-PEG ligands per AuMPC was calculated by 
dividing the total surface area of a spherical AuMPC by the SH-PEG molecular footprint.  
The maximum number of SH-PEG ligands per AuMPC was calculated for each particle 
size. 
 
Place Exchange Reaction.  A clear 20 mM solution of SH-PEG was generated by adding 
lyophilized SH-PEG to DI H2O at room temperature (23°C).  Unconjugated AuMPCs at 
their stock concentration were vortexed, to ensure even suspension in solution, and added 
to the SH-PEG solution at a 1:1 volumetric ratio.  Following a slow overnight stir, using a 
miniature magnetic stirring bar and stir plate thus allowing sufficient time for maximal 
functionalization, free citrate and unconjugated SH-PEG ligands were removed using a 
Thermo Fisher Scientific Inc. Slide-A-Lyzer® osmotic dialysis cassette with a membrane 
molecular weight cutoff of 10,000 MW.  PEGylated AuMPCs (PEG-S-AuMPCs) were 
harvested from the cassettes and stored at 5°C.  Three conjugation trials (n=3) were 
performed for each particle size to assess the variability of the conjugation protocol.   
 
Determination of Unknown AuMPC Concentrations.  Following the conjugation and 
osmotic dialysis of PEGylated AuMPCs, the resultant AuMPC concentration is unknown.  
In order to determine unknown concentrations, absorbance vs. known concentration 
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standard curves were generated for each particle size using unconjugated stock AuMPC 
solutions and UV-VIS analysis.  From the creation of the standard curves, both the molar 
extinction coefficient (ε) and the absorbance maxima (λ) were determined for each 
particle size. The absorbance values of conjugated AuMPC solutions of unknown 
concentration were then correlated to the standard curves using Beer’s law (A=εlc) to 
determine the subsequent concentration. 
 
Conjugation Confirmation.  Following the overnight place exchange reaction, SH-PEG 
conjugation was confirmed by monitoring the diameter of the AuMPCs with dynamic 
light scattering.  Stock solutions of the unconjugated AuMPCs were used as size controls 
for each particle diameter.  Each conjugation trial was evaluated to assess the variability 
of diameter increase due to the execution of the conjugation protocol.  PEG-S-AuMPCs 
were removed from the 5°C storage environment, allowed to warm to room temperature 
and vortexed for a minimum of five seconds to ensure colloidal resuspension.  1 ml of 
each conjugation trial was loaded into a low volume disposable cassette.  Prior to 
measurement initialization, each cuvette was tilted back and forth three times to ensure 
colloidal resuspension.  Typical count rates were between 100 and 350 kcps.  Size-
distribution profiles and average radii for each conjugation trial were obtained as the 
mean of triplicate measurements.  Each conjugated trial average diameter was statistically 
compared against the unconjugated control diameter using the Paired t-test. 
 
Determination of the Free Thiol Baseline.  In order to determine both the effectiveness of 
the osmotic dialysis at removal of the free thiol and to determine a baseline concentration 
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of the free SH-PEG ligands contained in the conjugated AuMPC solutions, a NMR-based 
free thiol measurement protocol was employed 
 
The most reliable form of compound quantification, and therefore primary form, 
available to the authors was 1H NMR.  Here, we instituted a novel method of reliably 
determining the free thiol baseline in each sample.  The free thiol baseline was measured 
via a 400 MHz instrument equipped with a 9.4 Tesla Oxford magnet controlled by a 
Bruker AV-400 console.  The main NMR probe for the instrument was a 5 mm Z-
gradient broadband inverse (BBI) probe with automatic tuning and matching capability 
(ATM).  Samples of each conjugation trial for each particle size were obtained and 
equalized to a concentration of 49 μM at a volume of 500 μl.  Each sample was placed 
into a Wilmad LabGlass (Vineland, NJ) 5MM Thin Wall, 7” Length, 500 MHz NMR 
tube.   
 
In order to quantify the number of ligands on the surface of the AuMPCs using NMR, the 
ligands must be removed from the surface of the nanoparticle.  In order to achieve this 
desorption, one to two large iodine (I2) crystals were added to each tube.  Chemically, the 
iodine has a higher affinity for the gold than the sulfur molecules [43].  Due to this 
disparity in affinity, the iodine decomposes the AuMPCs where the SH-PEG molecules 
are released into solution.  This place-exchange reaction of thiol for iodine to the gold 
clusters causes destabilization causing the iodinated gold to fall out of solution [44] into a 
dark brown solid.  Typically, when thiolated ligands desorb from gold particles, they 
form disulfide bonds [14].  In addition, iodine decomposition was allowed to occur to 
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completion for one hour as previously described [40] prior to spectrum measurement.  In 
order for the NMR to “lock” onto each sample, each tube was spiked with 50 μl of D2O 
creating a H2O+D2O based solvent. 
 
To ensure a spectrum of the decomposed gold and emancipated ligands could be 
acquired, a pre-saturation technique was employed to suppress the enormous peak 
typically generated by H2O. This allowed ample visualization of the more subtle peaks in 
the resulting spectrum. Each sample was measured following the same major parameters.  
The number of scans and receiver gain was held to 32.  For the f1 channel, P0 and P1 
were both held to 11.38 μs.  One spectrum was collected per sample to ensure conjugate 
desorption was occurring. 
 
In order to quantify the concentration of desorbed conjugates, the pre-saturation 
technique cannot be employed due to its inherent modulation of the spectrum baseline.  
Such modulation introduces error into any integral based quantification strategies.  
Therefore, a more common “zg30” program was used to acquire a spectrum for 
quantification methods to be implemented.  The number of scans was set to 16 whereas 
the receiver gain was held to 4.  A delay (D1) of 10 seconds was added between scans 
thus ensuring a large enough relaxation time to minimize the effect of the H2O peak on 
more subtle peaks. For the f1 channel, P1 was held to 11.38 μs.  One spectrum was 
acquired per sample and integration was used enumerate the ratio between the PEG chain 
terminal group, CH3-, peak and the disulfide, PEG-S-S-PEG, bond triplet peaks.  Prior to 
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any integration, all spectra were baseline corrected to zero using automatic and manual 
processes. 
 
A serial dilution was also performed in order to generate a standard curve relating 
concentration to integral-ratio.  In order to generate such integral-ratio values, the PEG 
terminal CH3- peak for a concentration of a 20 mM SH-PEG was directly compared to 
the CH3- peaks of samples containing lower concentrations of SH-PEG.  This comparison 
was achieved via spectral summation of the 20 mM SH-PEG with a ppm shifted spectra 
containing a lower conjugate concentration (APPENDIX C).  Integration was used in 
order to determine the integral-ratio between the 20 mM sample peak and the lesser 
concentration peak.  A standard curve was then generated from integral-ratios of all 
samples in comparison to the 20 mM peak. 
 
Desorbed-conjugate spectrums containing CH3- peaks were then compared to the 20 mM 
SH-PEG CH3- peak generating an integral-ratio.  This integral ratio can be used to 
quantify the concentration of PEG ligands in the desorbed-conjugate sample.  Using the 
difference in the integral-ratio between the CH3- peaks and the triplet disulfide (PEG-S-
S-PEG) peaks from unity (1-integral ratio), the number of S-PEG ligands that in no way 
came into contact with the gold colloid can be quantified. 
 
Quantification of Functionalized Conjugates.  The number of polyethylene glycol ligands 
conjugated to the surface of each AuMPC was quantified using a 720-ES Varian ICP-
AES.  Samples of each conjugation trial for each particle size were obtained and 
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equalized to a concentration of 49 μM at 5 ml in volume.  50 μl of 1% nitric acid in DI 
H2O was added to each sample to provide a viable matrix for the ICP-AES instrument.  
One emission wavelength per element was used to indicate the gold and the SH-PEG 
ligand concentration (267.54 and 181.972 nm for Au and S).  Using the certified 
elemental calibration standards, a 5-point calibration, including a blanked sample, was 
performed.  Samples and calibration standards, assayed at the same emission 
wavelengths, were compared for quantification in compliance with the following 
instrumental analysis conditions.  Nebulizer flow, necessary in order to spray the sample 
into the plasma, was held to 0.75 L/min.  The radio frequency power was adjusted to 1.2 
kW.  The plasma gas flow and auxiliary gas flow was held to 15 and 1.5 L/min.  The 
internal standard used for all of measurements was yttrium.  The replicate read time (read 
time per sample) was 5 sec and there were 3 replicates per reading.   Results for each 
conjugation trial per each particle size were exported in elemental concentrations of gold 
and sulfur in mg/L. 
 
The free thiol baseline from both the 1H NMR and Thiol Assay Kit were compared for 
congruency.  Following conversion of all units to molar concentrations, the relative free 
thiol concentration from the 1H NMR was subtracted from the total sulfur concentration 
yielding the true molar concentration of thiol groups attached to the AuMPCs.  These 
sulfur concentrations with their respective gold concentration were then expressed in 
sulfur molecules per AuMPC for each trial per each particle diameter. 
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Statistical Analysis.  Statistical Analysis was conducted using SigmaStat software.  
Paired t-tests were conducted with a confidence interval of 99%. 
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Results 
Determination of Unknown AuMPC Concentration.  In order to determine the AuMPC 
concentration following particle purification, the surface plasmon resonance was obtained 
by monitoring the UV-Vis spectra of each unconjugated particle size (Figure 3).  
Standard absorbance-concentration curves were produced (Figure 4).  The molar 
extinction coefficient was determined in accordance with Beer’s law.  The absorbance 
maxima (λ in mm) and molar extinction coefficients (ε in Lmol-1cm-1) are shown in Table 
1.  Following particle purification, the AuMPC concentrations were determined via 
Beer’s law by monitoring the absorbance maxima of the surface plasmon resonance 
curves (Figure 5). 
 
Conjugation Confirmation.  Particle conjugation was assessed by monitoring the 
hydrodynamic radii of each conjugation trial.  Used as a quantitative technique for 
qualitative assessment, significant increases in diameter increases were used to implicate 
conjugation. Dynamic light scattering results are shown in Figure 6.  Dynamic light 
scattering correctly sized unconjugated particle sizes.  The size increase of the AuMPCs 
following PEGylation was also monitored using DLS.  This size increase represents the 
radial thickness of the conjugated PEG coat and was found to be significantly different 
for all particle diameters except 5 nm. 
 
Determination of the Free Thiol Baseline.  The free thiol baseline was quantified using 
NMR spectroscopy.  Integral ratios between peaks were acquired and analyzed in 
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Bruker’s TopSpin program.  All non pre-saturated acquired and analyzed PEG-S-AuMPC 
spectrums depicting integral ratios used in this work are shown in APPENDIX B. 
 
As a proof of concept a serial dilution was used to create a standard curve relating 
integral ratio to concentration.  A coefficient of determination (R2) value larger than 0.9 
was used as a cutoff value to prove linear congruency.  The linear fit with R2 value and 
resulting equation is shown in Figure 8.  A R2 value of 0.9172 confirms the proof of 
concept of NMR assessment as a quantitative technique to determine ligand 
concentrations as low as 0.363 mM.  All acquired and analyzed PEG-SH serial dilutions 
used in this work are shown in APPENDIX A. 
 
As a further proof of concept, the differences in spectral response between PEG-SH and 
decomposed PEG-S-AuMPC samples were evaluated using pre-saturation method to 
remove the H2O proton peak that masks the ligand peaks and confirm the existence of 
quantifiable peaks.  An example of the spectral distinctions between PEG-SH protons and 
liberated PEG-S-S-PEG protons is shown in Figure 9.  The appearance of triplet peaks in 
the sulfide region suggests the expected formation of disulfide bonded liberated ligands.  
 
In order to obtain quantifiable spectra, the pre-saturation technique can not be used.  Non 
pre-saturated spectra were obtained and analyzed.  A sample analyzed spectrum is shown 
in Figure 10 whereas other spectra are shown in APPENDIX C.  The CH3- proton peak 
occurring at ~3.3 ppm represents the distal moiety at the end of the PEG polymer chain 
thus represents a single S-PEG ligand.  The triplet peak occurring between 2.8-2.9 ppm 
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represents the disulfide bond between two sulfur atoms of two S-PEG ligands.  The CH3- 
peak to disulfide triplet peak integral-ratios were uploaded into Microsoft Excel.  A 20 
mM SH-PEG CH3- peak was also compared to each liberated PEG-S-S-PEG CH3- peak 
generating an integral-ratio in order to quantify the concentration of PEG in each sample.  
Thus, unknown PEG-S-S-PEG concentrations were estimated by comparison of the –
CH3/disulfide peak integral ration with that generated by a 20 mM SH-EG standard. 
 
The free thiol baseline is calculated by first determining the free thiol integral-ratio – 
unity minus the integral ratio between the CH3- peak and PEG-S-S-PEG triplet peaks in 
the desorbed samples.  The free thiol concentration is then calculated by computing the 
free thiol integration with concentration of PEG in each sample.  
 
Quantification of Functionalized Conjugates.  Conjugated PEG-S ligands were quantified 
using inductively coupled plasma mass spectroscopy (ICP-AES).  Following the 
completion of the ICP-AES elemental concentration acquisition protocol, the 
concentrations of gold and sulfur elements were obtained in mg/L.  Each elemental 
concentration was baselined against the threshold gold and sulfur concentrations 
determined by the ICP-AES acquisition protocol.  The sulfur mass concentration was 
estimated from the ICP-AES measurement following subtraction of the corresponding 
free sulfur background as determined by NMR.  Number concentration of the PEG ligand 
was computed from the measured mass concentration of sulfur, the relative molecular 
masses of sulfur and the PEG ligand and Avogadro’s number.  The number concentration 
of AuMPCs was estimated from the measured gold mass using the density of bulk gold 
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(19.3 g/cm3) and the gold particle volume based on diameter.  As reported previously 
[41], the number of ligands per particle and the number of ligands per particle surface 
area were estimated.  The results of these experiments, comparison with one set of 
predicted values are shown in Figure 14 superimposed with NMR data from the previous 
chapter.  The qualitative trend in ligand association as a function of AuMPC size reported 
by ICP-AES is similar to those documented in the previous chapter for measurement by 
NMR and for a prediction based on a literature value.  The absolute ligand association 
values obtained by ICP-AES, based either on particle size or surface area, are one to three 
orders of magnitude greater than the corresponding results from NMR data.  Ligand 
packing density trends are shown in Figure 16.  Statistical significance between sample 
points is noted in each figure. 
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ICP-AES
Predicted
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 14.  Conjugated ligand enumeration (ICP-AES).  Top: number of ligands per 
particle as a function of particle diameter.  Bottom: number of ligands per particle 
as a function of particle surface area.  Data points represent the mean of three 
independent experiments with error bars as standard deviations.  *Significant size 
increase for p<0.05 using Paired T-Test, comparing means within each curve. 
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Discussion 
Studying the functionalization efficiency with respect to particle size was the overarching 
purpose of this work.  In our initial assessment, we hypothesized that the molecular 
footprint of PEG on the surface of gold was constant, but unknown, especially as a 
function of substrate dimensions.  Wuefling et al. estimated that the PEG-SH ligand 
footprint, the area occupied by the ligand on the surface of 2.8 nm gold particles, was 
0.35 nm2 [1].  Accordingly, we hypothesized that this ligand footprint held true across a 
range of particle sizes in a defect-free packing arrangement.  Predicted trends calculated 
based on Wueling et al. and extended to larger particle diameters are shown in Figure 13.  
 
In order to test this, the number of particles per particle surface area was calculated, thus 
elucidating the surface packing of PEG on gold over a range of nanoscale particle sizes.  
This is shown in Figure 16 as the density of PEG packing significantly increases as the 
particle size increases across the range of 5 nm to 100 nm.  However, this trend of 
significant increase does not continue as steeply from 100 nm to 250 nm.  It can be 
generally inferred that the packing density decreases as available particulate surface area 
decreases.  Confirmation and assessment of this trend and its implications must first be 
carried out through comparison of the ligand enumeration with theoretical prediction. 
 
Ligand enumeration using ICP-AES follows the same qualitative relationship with 
particle size and surface area as obtained by both theoretical prediction and NMR (Figure 
14).  The primary difference between all enumerative plots is the quantitative disparity 
between the prediction and each method.  However, these disparities can be numerically 
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related though a scaling factor.  Results obtained from ICP-AES and NMR data and the 
predicted values can be normalized relative to the corresponding result for the 250 nm 
diameter particle in order to directly compare differences in ligand enumeration.  The 
result of this data normalization is shown in Figure 15.  Here, we speculate the 
differences in scaling between the enumerative methods and the predicted data represent 
both the inefficiency of the free thiol baseline strategy or the purification strategy used to 
remove free thiol and free disulfide bonded ligands from the reaction solution.  Further, 
PEG-S-AuMPC samples in aerosol form tend to get lodged in the central channel of the 
ICP-AES causing cross-contamination and slight imperfections in data acquisition.  
These cross-contaminations are generally controlled by baseline protocols inherent in the 
acquisition procedure; but may still allow artifacts to be registered in the current sample.  
These artifacts usually register higher sample concentrations than really exist thus adding 
to the disparity between the predicted and acquired data above.  Such disparities however 
have no bearing on trends formed though analysis of the data and further supports the 
effectiveness of both enumerative strategies at determining the amount of ligand in each 
sample.  
 
An additional observation that can be noted from Figure 15 is that ligand coverage 
increases by over three orders of magnitude as particle diameters increase from 5 nm to 
250 nm across both enumerative methods.  Efficiency is maximized at 250 nm thus 
ligand packing efficiency is 50 to 100 times less for the smallest particles studied here.  It 
can be speculated that such limitations at smaller sizes are governed both by certain 
ligand and particle characteristics that will be discussed shortly.  
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Figure 15.  Normalized enumerative and ligand packing data.  Both the ICP-AES 
and NMR data can normalized in order to directly compare differences in ligand 
enumeration from the predicted data by normalizing all data sets to their respective 
250 nm particle. 
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PEG functionalization of AuMPCs measured by ICP-AES and NMR (Figure 14) follow 
the same qualitative trend as a function of particle surface area, but the enumerative data 
ranges from one to two orders of magnitude lower for the NMR data.  This disparity can 
be explained due to the differences in the acquisitions of ligand concentrations.  NMR, as 
shown in Figure 8, is a highly sensitive instrument relying on the magnetic resonance of 
nuclei to determine sample concentrations.  The NMR technique can distinctly decipher 
liberated – previously conjugated - ligands from free ligands in solution due to 
differences in nuclear resonance; however, ICP-AES relies on an external baseline 
protocol to remove free ligands.  Neither method however is completely efficient at 
resolving the difference between free and conjugated ligands – especially when their 
emission and resonance profiles are synonymous.  These issues, however, do not prevent 
useful analysis of the ligand packing trends as a function of particle size, which is the 
primary objective of this work. 
 
The ligand packing density significantly decreases as available particulate surface area 
decreases for particle sizes 5 nm to 100 nm.  In addition, the packing density begins to 
become more constant for sizes ranging from 100 nm to 250 nm.  It can be speculated 
that the packing density for these larger sizes is governed by characteristics of the particle 
and ligand.  These speculative claims are supported by the characteristics of PEG and its 
conformational loading on gold particles. 
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Results from both analytical methods suggest that PEG surface packing density at the 
nanoscale decreases as available particle surface area decreases.  A number of plausible 
physical and chemical interpretations are consistent with this trend.  Steric hindrance of 
bound PEG molecules may impede the attachment of subsequent PEG association due to 
the length of the 5000 MW polymer [54].  For example, a single, surface-attached PEG 
molecule may be sufficiently long and flexible to block potential binding sites.  An 
estimate of the potential for such bound-PEG inhibition of additional conjugation was 
carried out.  PEG chain lengths were estimated using the average molecular weight of 
5000 MW to calculate the number of monomers in each chain, n=112. The length of each 
monomer was estimated to be ~49.9 nm using linear bond lengths: C-C, 154 pm; C-O, 
143 pm; C-S, 181 pm.  In addition, the atom sizes were implemented using atomic 
diameters: C, 0.182 nm; O, 0.13 nm; S, 0.218 nm.  Using these estimations and the 
commercially reported AuMPC diameters, a PEG length to particle diameter ratio was 
generated.  Once can theoretically envision a functionalization circumstance where there 
are at least two idealized components represented: 1) the PEG molecules label gold 
straight (rather than coiled) and each polymer is projected normal to the AuMPC surface 
(rather than at a different orientation).  Here, we would theoretically perceive that the 
surface area a single ligand occupies is invariable thus leading to a constant packing 
density across varying particle sizes.  Departures from this ideal state will cause the 
bound PEG to occupy a proportionally greater surface area and reduce the capacity for 
additional PEG association with the AuMPC surface.  Thus, it seems likely that steric 
hindrance in the experimental study would reduce the measured extent of PEG chain 
conjugation relative to the idealized, theoretical trend especially for smaller particles with 
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less available surface area.  Further, idealized PEG length is twenty-fold greater than the 
5 nm diameter AuMPC, but only 40% of the 250 nm diameter particle thus increasing the 
probability that PEG will sterically hinder other polymer ligands especially at lower 
particle sizes. 
   
Other factors may contribute to the observed departure from ideality.  Studies have 
shown that PEG can assume a range of molecular conformations modulated by the local 
environment due to its malleability [55].  For example, PEG sparsely bound to surfaces 
has the opportunity to form self-associations that result in a ‘mushroom’ shape that 
occupies a larger cross-sectional area than the simple molecular diameter.  This PEG 
characteristic supports the enumerative findings and is further substantiated by the post-
conjugation size increase of larger particle sizes (Figure 7).  DLS data confirms that 
particle diameters of 150 nm and 250 nm have significantly thicker PEG coats than the 
smaller particles.  The coat thickness for these particle sizes is also coupled with a large 
increase in available surface area.  Our previous speculation inferred that there exists a 
maximal packing density as particle size increases.  Keeping in mind that the initial PEG 
mass was added to the functionalization reaction in excess, we can speculate that this 
maximal packing density is a function of the particle size, PEG length, and PEG 
conformational malleability. Between these two particle sizes, we can infer that there is a 
point where the available surface area is large enough to allow PEG of a certain length, to 
form blob-like ‘mushroom’ conformations instead of more erect ‘brush’ conformations.  
Although this change in PEG conformation will increase ligand footprint, any significant  
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Figure 16.  Surface packing of PEG on AuMPC as a function of particle surface 
area as quantified using ICP-AES (top) and NMR (bottom).  Surface packing is 
defined as number of PEG ligands per particle surface area.  ( - ) represents the 
predicted trend for each enumeration strategy if the ligand footprint remains 
constant over all particle sizes.  Data points represent the mean of three independent 
experiments with error bars as standard deviations.  *Significant size increase for 
p<0.05 using Paired T-Test for means within a single curve 
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increase in particle size will increase the available surface area such that the number of 
ligands per particle will continue to increase.  From the experimental data, it can be 
concluded that this transition point for 5000 MW PEG occurs between 100 nm and 250 
nm particle sizes – at a point where the erect length of the conjugated ligand 
approximates the particle diameter.  Although such molecular conformations may be 
responsible, in whole or in part, for the observed trends in PEG-S-AuMPC 
functionalization, the scope of this study does not include such precise assessments.  
Nevertheless, the comparison of experimental results with theory suggest that PEG 
packing is more efficient on particles where its diameter approximates the erect length of 
the conjugated polymer - potentially implying that the potential for maximizing or 
enhancing bionanoparticulate effectiveness lies in the careful design and knowledge of 
the loading and packing profile of the protecting or targeting ligand that will be loaded on 
the desired particulate platform.  
 
The ligand density of nanoparticles intended for use in living systems is a critical 
modulator of specific functions.  Many biological functions depend on the activation 
multiple moieties to establish the desired effect.  Because of this, knowledge of the ligand 
density is paramount in determining the effectiveness of the nanoparticle at stimulating 
the desired biological effect.  Functionalization approaches that are successful in vitro on 
relatively large scale surfaces, or in proof-of-concept studies on microparticles may prove 
to be different – and possibly inadequate – as the achievable surface density decreases 
with particle size the nanoscale.  In addition, accepted transport properties on the 
macroscale do not translate to studies carried out on the micro- or nanoscale because of 
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unique nanoscale behavior and environment.  Because of this, nanoscale based studies - 
like the above - characterizing functionalization, enumerating ligand density, and 
determining ligand conformation must be performed to obtain the knowledge necessary 
to effectively design, synthesize and implement efficient theranostic pharmaceuticals and 
bionanotechnology based drug delivery systems. 
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CHAPTER IV 
 
CONCLUSIONS AND FUTURE WORK 
 
Conclusions 
Bionanotechnology is a field quickly gaining popularity among researchers seeking to 
specifically target cancer and pathogens for diagnostics and treatment.  Most targeting 
agents require surface protection and passivation to improve vascular circulation time, 
delivery probability and biocompatibility.  The protective and targeting efficiency of such 
nanotechnology is characterized by the number of protective and targeting ligands on the 
particle.  In order to characterize the therapeutic capacity of such ligand-coated particles, 
the number of ligands bound must be quantified.  To accomplish this, previous studies 
used molecularly-tethered or fluorescently-tagged ligands which affect surface packing.  
Here, a “label-free” method of conjugate quantification was described thus circumventing 
the disadvantageous surface packing disparity introduced by previous methods. 
 
Conjugated PEG-S ligands were quantified using 1H nuclear magnetic resonance (NMR) 
spectroscopy and inductively coupled plasma mass spectroscopy (ICP-AES).  Both the 
NMR and ICP-AES enumeration of conjugated ligands aligned with assumed predicted 
considerations following the implementation of normalization. The ligand packing 
density significantly decreases as available particulate surface area decreases for particle 
sizes 5 nm to 100 nm.  Steric hindrance and the inherent conformational malleability of 
PEG is presumed to decrease total ligand binding from the predicted considerations and 
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cause this decreasing trend for lower particle sizes.  In addition, the packing density 
begins to become more constant for sizes ranging from 100 nm to 250 nm.  It can be 
speculated that the packing density for these larger sizes are governed by some 
characteristic of the particle or ligand for sizes.  From the experimental data, it can be 
concluded that this transition point for 5000 MW PEG occurs between 100 nm and 250 
nm particle sizes – at a point where the erect length of the conjugated ligand 
approximates the particle diameter.  The comparison of experimental results with theory 
suggest that PEG packing is more efficient on particles where its diameter approximates 
the erect length of the conjugated polymer - potentially implying that the potential for 
maximizing or enhancing bionanoparticulate effectiveness lies in the careful design and 
knowledge of the loading and packing profile of the protecting or targeting ligand that 
will be loaded on the desired particulate platform. 
 
This work on this enumerative technique, along with future expansion, will provide 
investigators with the ability to quantify the number of ligands on the surface of their 
nanoscale constructs.  Such knowledge will enable investigators insight into the efficacy 
of their nanotechnology as it is related to, and possibly governed by, the surface 
functionalization efficiency. 
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Future Work 
The ultimate goal of this work was to establish a “label-free” strategy to determine the 
functionalization efficiency of gold nanoparticles over a range of nanoparticle sizes.  The 
future of this work is to further elucidate the factors that govern functionalization and 
ligand surface packing.  In addition, the present work has generated new questions 
regarding the molecular principles that control the surface functionalizion of long ligands 
to an assortment of particles. 
 
Reconciliation of the enumerative data from the NMR and ICP-AES studies should be 
attempted experimentally without a correction factor.  DLS results can be supported by 
data acquired from transmission electron microscopy.  A PEG stain could be used to 
quantitatively monitor the size increase of AuMPCs following conjugation using TEM.  
This approach will be helpful in determining PEG conformations following conjugation. 
 
Further studies could investigate other factors that govern functionalization and ligand 
surface packing.  Instead of varying particle size, the initial PEG concentration used to 
initiate conjugation processes could be varied across a single particles size.  Furthermore, 
these experiments could be extended across particles sizes.  Also, PEG conformation 
could be monitored across a range of particles sizes to support the speculation in this 
study.  Once this is determined, surface protection as a function of PEG conformation 
could also be investigated.  These further studies will provide definitive insight as to how 
PEG conformation on the particle surface affects both packing and surface passivation.  
Even further, researchers could use these new studies to generate conformation - 
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functionalization profiles for individual ligands.  Such studies would further provide 
investigators invaluable insight into how to best conjugate their nanoscale materials for 
biological and medical applications. 
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